Chaisson, Richard E.

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 3,098

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 2,119

A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

Churchyard, G. J., Fielding, K. L., Lewis, J. J., Coetzee, L., Corbett, E. L., Godfrey-Faussett, P., Hayes, R. J., Chaisson, R. E., & Grant, A. D. (2014) · New England Journal of Medicine

Tuberculosis Research and EpidemiologyHIV, TB, and STIs Epidemiology

Cited by 238

Paradoxical Worsening of Tuberculosis in HIV-Infected Persons

Wendel, K. A., Alwood, K. S., Gachuhi, R., Chaisson, R. E., Bishai, W. R., & Sterling, T. R. (2001) · Chest

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 157

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., et al. (2023) · The Lancet

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 87